Jeroen Geurts - Publications

Affiliations: 
VU University Medical Center, Amsterdam, Netherlands 
Area:
Neurodegenerative diseases
Website:
https://www.knaw.nl/nl/profiles/13408

205 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2024 Koubiyr I, Krijnen EA, Eijlers AJC, Dekker I, Hulst HE, Uitdehaag BMJ, Barkhof F, Geurts JJG, Schoonheim MM. Longitudinal fibre-specific white matter damage predicts cognitive decline in multiple sclerosis. Brain Communications. 6: fcae018. PMID 38344654 DOI: 10.1093/braincomms/fcae018  0.482
2023 van Dam M, de Jong BA, Willemse EAJ, Nauta IM, Huiskamp M, Klein M, Moraal B, de Geus-Driessen S, Geurts JJG, Uitdehaag BMJ, Teunissen CE, Hulst HE. A multimodal marker for cognitive functioning in multiple sclerosis: the role of NfL, GFAP and conventional MRI in predicting cognitive functioning in a prospective clinical cohort. Journal of Neurology. PMID 37101095 DOI: 10.1007/s00415-023-11676-4  0.311
2023 Bouman PM, Noteboom S, Nobrega Santos FA, Beck ES, Bliault G, Castellaro M, Calabrese M, Chard DT, Eichinger P, Filippi M, Inglese M, Lapucci C, Marciniak A, Moraal B, Morales Pinzon A, ... ... Geurts JJG, et al. Multicenter Evaluation of AI-generated DIR and PSIR for Cortical and Juxtacortical Multiple Sclerosis Lesion Detection. Radiology. 221425. PMID 36749211 DOI: 10.1148/radiol.221425  0.392
2022 Strik M, Eijlers AJ, Dekker I, Broeders TA, Douw L, Killestein J, Kolbe SC, Geurts JJ, Schoonheim MM. Sensorimotor network dynamics predict decline in upper and lower limb function in people with multiple sclerosis. Multiple Sclerosis (Houndmills, Basingstoke, England). 13524585221125372. PMID 36177896 DOI: 10.1177/13524585221125372  0.311
2022 Carotenuto A, Valsasina P, Schoonheim MM, Geurts JJ, Barkhof F, Gallo A, Tedeschi G, Tommasin S, Pantano P, Filippi M, Rocca MA. Investigating Functional Network Abnormalities and Associations With Disability in Multiple Sclerosis. Neurology. PMID 36096690 DOI: 10.1212/WNL.0000000000201264  0.492
2022 Hosseinpour Z, Jonkman L, Oladosu O, Pridham G, Pike GB, Inglese M, Geurts JJ, Zhang Y. Texture analysis in brain T2 and diffusion MRI differentiates histology-verified grey and white matter pathology types in multiple sclerosis. Journal of Neuroscience Methods. 379: 109671. PMID 35820450 DOI: 10.1016/j.jneumeth.2022.109671  0.432
2022 Prouskas SE, Schoonheim MM, Huiskamp M, Steenwijk MD, Gehring K, Barkhof F, de Jong BA, Sitskoorn MM, Geurts JJ, Hulst HE. A randomized trial predicting response to cognitive rehabilitation in multiple sclerosis: Is there a window of opportunity? Multiple Sclerosis (Houndmills, Basingstoke, England). 13524585221103134. PMID 35765748 DOI: 10.1177/13524585221103134  0.367
2022 Koubiyr I, Broeders TA, Deloire M, Brochet B, Tourdias T, Geurts JJ, Schoonheim MM, Ruet A. Altered functional brain states predict cognitive decline 5 years after a clinically isolated syndrome. Multiple Sclerosis (Houndmills, Basingstoke, England). 13524585221101470. PMID 35735004 DOI: 10.1177/13524585221101470  0.304
2022 Kulik SD, Nauta IM, Tewarie P, Koubiyr I, van Dellen E, Ruet A, Meijer KA, de Jong BA, Stam CJ, Hillebrand A, Geurts JJG, Douw L, Schoonheim MM. Structure-function coupling as a correlate and potential biomarker of cognitive impairment in multiple sclerosis. Network Neuroscience (Cambridge, Mass.). 6: 339-356. PMID 35733434 DOI: 10.1162/netn_a_00226  0.339
2022 Rocca MA, Schoonheim MM, Valsasina P, Geurts JJG, Filippi M. Task- and resting-state fMRI studies in multiple sclerosis: From regions to systems and time-varying analysis. Current status and future perspective. Neuroimage. Clinical. 35: 103076. PMID 35691253 DOI: 10.1016/j.nicl.2022.103076  0.364
2022 Broeders TAA, Douw L, Eijlers AJC, Dekker I, Uitdehaag BMJ, Barkhof F, Hulst HE, Vinkers CH, Geurts JJG, Schoonheim MM. A more unstable resting-state functional network in cognitively declining multiple sclerosis. Brain Communications. 4: fcac095. PMID 35620116 DOI: 10.1093/braincomms/fcac095  0.418
2022 Ghorbani S, Jelinek E, Jain R, Buehner B, Li C, Lozinski BM, Sarkar S, Kaushik DK, Dong Y, Wight TN, Karimi-Abdolrezaee S, Schenk GJ, Strijbis EM, Geurts J, Zhang P, et al. Versican promotes T helper 17 cytotoxic inflammation and impedes oligodendrocyte precursor cell remyelination. Nature Communications. 13: 2445. PMID 35508608 DOI: 10.1038/s41467-022-30032-0  0.389
2022 van Wageningen TA, Gerrits E, Brouwer N, Brevé JJP, Geurts JJG, Eggen BJL, Boddeke HWGME, van Dam AM. Distinct gene expression in demyelinated white and grey matter areas of patients with multiple sclerosis. Brain Communications. 4: fcac005. PMID 35282162 DOI: 10.1093/braincomms/fcac005  0.362
2022 Bouman PM, Steenwijk MD, Geurts JJG, Jonkman LE. Artificial double inversion recovery images can substitute conventionally acquired images: an MRI-histology study. Scientific Reports. 12: 2620. PMID 35173226 DOI: 10.1038/s41598-022-06546-4  0.351
2021 Huitema MJD, Strijbis EMM, Luchicchi A, Bol JGJM, Plemel JR, Geurts JJG, Schenk GJ. Myelin Quantification in White Matter Pathology of Progressive Multiple Sclerosis Post-Mortem Brain Samples: A New Approach for Quantifying Remyelination. International Journal of Molecular Sciences. 22. PMID 34884445 DOI: 10.3390/ijms222312634  0.409
2021 Elliott C, Momayyezsiahkal P, Arnold DL, Liu D, Ke J, Zhu L, Zhu B, George IC, Bradley DP, Fisher E, Cahir-McFarland E, Stys PK, Geurts JJG, Franchimont N, Gafson A, et al. Abnormalities in normal-appearing white matter from which multiple sclerosis lesions arise. Brain Communications. 3: fcab176. PMID 34557664 DOI: 10.1093/braincomms/fcab176  0.441
2021 Bouman PM, Strijbis VI, Jonkman LE, Hulst HE, Geurts JJ, Steenwijk MD. Artificial double inversion recovery images for (juxta)cortical lesion visualization in multiple sclerosis. Multiple Sclerosis (Houndmills, Basingstoke, England). 13524585211029860. PMID 34259591 DOI: 10.1177/13524585211029860  0.382
2021 't Hart BA, Luchicchi A, Schenk GJ, Stys PK, Geurts JJG. Mechanistic underpinning of an inside-out concept for autoimmunity in multiple sclerosis. Annals of Clinical and Translational Neurology. PMID 34156169 DOI: 10.1002/acn3.51401  0.367
2021 Huiskamp M, Eijlers AJC, Broeders TAA, Pasteuning J, Dekker I, Uitdehaag BMJ, Barkhof F, Wink AM, Geurts JJG, Hulst HE, Schoonheim MM. Longitudinal Network Changes and Conversion to Cognitive Impairment in Multiple Sclerosis. Neurology. PMID 34099528 DOI: 10.1212/WNL.0000000000012341  0.428
2021 't Hart BA, Luchicchi A, Schenk GJ, Killestein J, Geurts JJG. Multiple sclerosis and drug discovery: A work of translation. Ebiomedicine. 68: 103392. PMID 34044219 DOI: 10.1016/j.ebiom.2021.103392  0.323
2021 Granziera C, Wuerfel J, Barkhof F, Calabrese M, De Stefano N, Enzinger C, Evangelou N, Filippi M, Geurts JJG, Reich DS, Rocca MA, Ropele S, Rovira À, Sati P, Toosy AT, et al. Quantitative magnetic resonance imaging towards clinical application in multiple sclerosis. Brain : a Journal of Neurology. PMID 33970206 DOI: 10.1093/brain/awab029  0.509
2021 Schoonheim MM, Pinter D, Prouskas SE, Broeders TA, Pirpamer L, Khalil M, Ropele S, Uitdehaag BM, Barkhof F, Enzinger C, Geurts JJ. Disability in multiple sclerosis is related to thalamic connectivity and cortical network atrophy. Multiple Sclerosis (Houndmills, Basingstoke, England). 13524585211008743. PMID 33870779 DOI: 10.1177/13524585211008743  0.516
2021 van Olst L, Rodriguez-Mogeda C, Picon C, Kiljan S, James RE, Kamermans A, van der Pol SMA, Knoop L, Michailidou I, Drost E, Franssen M, Schenk GJ, Geurts JJG, Amor S, Mazarakis ND, et al. Meningeal inflammation in multiple sclerosis induces phenotypic changes in cortical microglia that differentially associate with neurodegeneration. Acta Neuropathologica. PMID 33779783 DOI: 10.1007/s00401-021-02293-4  0.36
2021 Tijhuis FB, Broeders TAA, Santos FAN, Schoonheim MM, Killestein J, Leurs CE, van Geest Q, Steenwijk MD, Geurts JJG, Hulst HE, Douw L. Dynamic functional connectivity as a neural correlate of fatigue in multiple sclerosis. Neuroimage. Clinical. 29: 102556. PMID 33472144 DOI: 10.1016/j.nicl.2020.102556  0.405
2021 Oudejans E, Luchicchi A, Strijbis EMM, Geurts JJG, van Dam AM. Is MS affecting the CNS only? Lessons from clinic to myelin pathophysiology. Neurology(R) Neuroimmunology & Neuroinflammation. 8. PMID 33234720 DOI: 10.1212/NXI.0000000000000914  0.4
2020 Dekker I, Schoonheim MM, Venkatraghavan V, Eijlers AJC, Brouwer I, Bron EE, Klein S, Wattjes MP, Wink AM, Geurts JJG, Uitdehaag BMJ, Oxtoby NP, Alexander DC, Vrenken H, Killestein J, et al. The sequence of structural, functional and cognitive changes in multiple sclerosis. Neuroimage. Clinical. 29: 102550. PMID 33418173 DOI: 10.1016/j.nicl.2020.102550  0.465
2020 Nauta IM, Kulik SD, Breedt LC, Eijlers AJ, Strijbis EM, Bertens D, Tewarie P, Hillebrand A, Stam CJ, Uitdehaag BM, Geurts JJ, Douw L, de Jong BA, Schoonheim MM. Functional brain network organization measured with magnetoencephalography predicts cognitive decline in multiple sclerosis. Multiple Sclerosis (Houndmills, Basingstoke, England). 1352458520977160. PMID 33295249 DOI: 10.1177/1352458520977160  0.319
2020 Strik M, Chard DT, Dekker I, Meijer KA, Eijlers AJ, Pardini M, Uitdehaag BM, Kolbe SC, Geurts JJ, Schoonheim MM. Increased functional sensorimotor network efficiency relates to disability in multiple sclerosis. Multiple Sclerosis (Houndmills, Basingstoke, England). 1352458520966292. PMID 33104448 DOI: 10.1177/1352458520966292  0.341
2020 Butzkueven H, Licata S, Jeffery D, Arnold DL, Filippi M, Geurts JJ, Santra S, Campbell N, Ho PR. Natalizumab versus fingolimod for patients with active relapsing-remitting multiple sclerosis: results from REVEAL, a prospective, randomised head-to-head study. Bmj Open. 10: e038861. PMID 33082194 DOI: 10.1136/bmjopen-2020-038861  0.309
2020 Bouman PM, Steenwijk MD, Pouwels PJW, Schoonheim MM, Barkhof F, Jonkman LE, Geurts JJG. Histopathology-validated recommendations for cortical lesion imaging in multiple sclerosis. Brain : a Journal of Neurology. PMID 32889535 DOI: 10.1093/Brain/Awaa233  0.499
2020 Kiljan S, Preziosa P, Jonkman LE, van de Berg WD, Twisk J, Pouwels PJ, Schenk GJ, Rocca MA, Filippi M, Geurts JJ, Steenwijk MD. Cortical axonal loss is associated with both gray matter demyelination and white matter tract pathology in progressive multiple sclerosis: Evidence from a combined MRI-histopathology study. Multiple Sclerosis (Houndmills, Basingstoke, England). 1352458520918978. PMID 32390507 DOI: 10.1177/1352458520918978  0.366
2019 Boon BDC, Pouwels PJW, Jonkman LE, Keijzer MJ, Preziosa P, van de Berg WDJ, Geurts JJG, Scheltens P, Barkhof F, Rozemuller AJM, Bouwman FH, Steenwijk MD. Can MRI be used as a proxy for ? A case study. Brain Communications. 1: fcz030. PMID 32954270 DOI: 10.1093/braincomms/fcz030  0.453
2019 van Wageningen TA, Vlaar E, Kooij G, Jongenelen CAM, Geurts JJG, van Dam AM. Regulation of microglial TMEM119 and P2RY12 immunoreactivity in multiple sclerosis white and grey matter lesions is dependent on their inflammatory environment. Acta Neuropathologica Communications. 7: 206. PMID 31829283 DOI: 10.1186/s40478-019-0850-z  0.46
2019 van Dongen L, Westerik B, van der Hiele K, Visser LH, Schoonheim MM, Douw L, Twisk JWR, de Jong BA, Geurts JJG, Hulst HE. Introducing Multiple Screener: An unsupervised digital screening tool for cognitive deficits in MS. Multiple Sclerosis and Related Disorders. 38: 101479. PMID 31760365 DOI: 10.1016/j.msard.2019.101479  0.332
2019 Eijlers AJC, Dekker I, Steenwijk MD, Meijer KA, Hulst HE, Pouwels PJW, Uitdehaag BMJ, Barkhof F, Vrenken H, Schoonheim MM, Geurts JJG. Cortical atrophy accelerates as cognitive decline worsens in multiple sclerosis. Neurology. PMID 31484713 DOI: 10.1212/Wnl.0000000000008198  0.514
2019 Dekker I, Sombekke MH, Balk LJ, Moraal B, Geurts JJ, Barkhof F, Uitdehaag BM, Killestein J, Wattjes MP. Infratentorial and spinal cord lesions: Cumulative predictors of long-term disability? Multiple Sclerosis (Houndmills, Basingstoke, England). 1352458519864933. PMID 31373535 DOI: 10.1177/1352458519864933  0.427
2019 Filippi M, Preziosa P, Banwell BL, Barkhof F, Ciccarelli O, De Stefano N, Geurts JJG, Paul F, Reich DS, Toosy AT, Traboulsee A, Wattjes MP, Yousry TA, Gass A, Lubetzki C, et al. Assessment of lesions on magnetic resonance imaging in multiple sclerosis: practical guidelines. Brain : a Journal of Neurology. PMID 31209474 DOI: 10.1093/Brain/Awz144  0.551
2019 Preziosa P, Kiljan S, Steenwijk MD, Meani A, van de Berg WDJ, Schenk GJ, Rocca MA, Filippi M, Geurts JJG, Jonkman LE. Axonal degeneration as substrate of fractional anisotropy abnormalities in multiple sclerosis cortex. Brain : a Journal of Neurology. PMID 31168614 DOI: 10.1093/brain/awz143  0.331
2019 Jonkman LE, Kenkhuis B, Geurts JJG, van de Berg WDJ. Post-Mortem MRI and Histopathology in Neurologic Disease: A Translational Approach. Neuroscience Bulletin. PMID 30790214 DOI: 10.1007/s12264-019-00342-3  0.301
2019 Jonkman LE, Graaf YG, Bulk M, Kaaij E, Pouwels PJW, Barkhof F, Rozemuller AJM, van der Weerd L, Geurts JJG, van de Berg WDJ. Normal Aging Brain Collection Amsterdam (NABCA): A comprehensive collection of postmortem high-field imaging, neuropathological and morphometric datasets of non-neurological controls. Neuroimage. Clinical. 22: 101698. PMID 30711684 DOI: 10.1016/J.Nicl.2019.101698  0.361
2019 Filippi M, Brück W, Chard D, Fazekas F, Geurts JJG, Enzinger C, Hametner S, Kuhlmann T, Preziosa P, Rovira À, Schmierer K, Stadelmann C, Rocca MA. Association between pathological and MRI findings in multiple sclerosis. The Lancet. Neurology. 18: 198-210. PMID 30663609 DOI: 10.1016/S1474-4422(18)30451-4  0.367
2018 Kiljan S, Meijer KA, Steenwijk MD, Pouwels PJW, Schoonheim MM, Schenk GJ, Geurts JJG, Douw L. Structural network topology relates to tissue properties in multiple sclerosis. Journal of Neurology. PMID 30467603 DOI: 10.1007/S00415-018-9130-2  0.328
2018 Schoonhoven DN, Fraschini M, Tewarie P, Uitdehaag BM, Eijlers AJ, Geurts JJ, Hillebrand A, Schoonheim MM, Stam CJ, Strijbis EM. Resting-state MEG measurement of functional activation as a biomarker for cognitive decline in MS. Multiple Sclerosis (Houndmills, Basingstoke, England). 1352458518810260. PMID 30465461 DOI: 10.1177/1352458518810260  0.363
2018 Rocca MA, Barkhof F, De Luca J, Frisén J, Geurts JJG, Hulst HE, Sastre-Garriga J, Filippi M. The hippocampus in multiple sclerosis. The Lancet. Neurology. 17: 918-926. PMID 30264730 DOI: 10.1016/S1474-4422(18)30309-0  0.445
2018 Eijlers AJC, van Geest Q, Dekker I, Steenwijk MD, Meijer KA, Hulst HE, Barkhof F, Uitdehaag BMJ, Schoonheim MM, Geurts JJG. Predicting cognitive decline in multiple sclerosis: a 5-year follow-up study. Brain : a Journal of Neurology. 141: 2605-2618. PMID 30169585 DOI: 10.1093/Brain/Awy202  0.489
2018 Amiri H, de Sitter A, Bendfeldt K, Battaglini M, Gandini Wheeler-Kingshott CAM, Calabrese M, Geurts JJG, Rocca MA, Sastre-Garriga J, Enzinger C, de Stefano N, Filippi M, Rovira Á, Barkhof F, Vrenken H, et al. Urgent challenges in quantification and interpretation of brain grey matter atrophy in individual MS patients using MRI. Neuroimage. Clinical. 19: 466-475. PMID 29984155 DOI: 10.1016/J.Nicl.2018.04.023  0.514
2018 Eijlers AJC, Meijer KA, van Geest Q, Geurts JJG, Schoonheim MM. Determinants of Cognitive Impairment in Patients with Multiple Sclerosis with and without Atrophy. Radiology. 172808. PMID 29786489 DOI: 10.1148/radiol.2018172808  0.364
2018 Eshaghi A, Marinescu RV, Young AL, Firth NC, Prados F, Jorge Cardoso M, Tur C, De Angelis F, Cawley N, Brownlee WJ, De Stefano N, Laura Stromillo M, Battaglini M, Ruggieri S, Gasperini C, ... ... Geurts JJG, et al. Progression of regional grey matter atrophy in multiple sclerosis. Brain : a Journal of Neurology. PMID 29741648 DOI: 10.1093/Brain/Awy088  0.51
2018 Tewarie P, Steenwijk MD, Brookes MJ, Uitdehaag BMJ, Geurts JJG, Stam CJ, Schoonheim MM. Explaining the heterogeneity of functional connectivity findings in multiple sclerosis: An empirically informed modeling study. Human Brain Mapping. PMID 29468785 DOI: 10.1002/hbm.24020  0.339
2017 Benedict RHB, DeLuca J, Enzinger C, Geurts JJG, Krupp LB, Rao SM. Neuropsychology of Multiple Sclerosis: Looking Back and Moving Forward. Journal of the International Neuropsychological Society : Jins. 23: 832-842. PMID 29198279 DOI: 10.1017/S1355617717000959  0.418
2017 de Jong MC, de Graaf P, Pouwels PJW, Beenakker JW, Jansen RW, Geurts JJG, Moll AC, Castelijns JA, van der Valk P, van der Weerd L. 9.4T and 17.6T MRI of Retinoblastoma: Ex Vivo evaluation of microstructural anatomy and disease extent compared with histopathology. Journal of Magnetic Resonance Imaging : Jmri. PMID 29193569 DOI: 10.1002/Jmri.25913  0.464
2017 Nauta IM, Speckens AEM, Kessels RPC, Geurts JJG, de Groot V, Uitdehaag BMJ, Fasotti L, de Jong BA. Cognitive rehabilitation and mindfulness in multiple sclerosis (REMIND-MS): a study protocol for a randomised controlled trial. Bmc Neurology. 17: 201. PMID 29162058 DOI: 10.1186/s12883-017-0979-y  0.313
2017 Dekker I, Sombekke MH, Witte BI, Geurts JJ, Barkhof F, Uitdehaag BM, Killestein J, Wattjes MP. Asymptomatic spinal cord lesions do not predict the time to disability in patients with early multiple sclerosis. Multiple Sclerosis (Houndmills, Basingstoke, England). 1352458517736147. PMID 29106327 DOI: 10.1177/1352458517736147  0.47
2017 Meijer KA, Eijlers AJC, Geurts JJG, Schoonheim MM. Staging of cortical and deep grey matter functional connectivity changes in multiple sclerosis. Journal of Neurology, Neurosurgery, and Psychiatry. PMID 28986469 DOI: 10.1136/jnnp-2017-316329  0.383
2017 Tobyne SM, Ochoa WB, Bireley JD, Smith VM, Geurts JJ, Schmahmann JD, Klawiter EC. Cognitive impairment and the regional distribution of cerebellar lesions in multiple sclerosis. Multiple Sclerosis (Houndmills, Basingstoke, England). 1352458517730132. PMID 28933672 DOI: 10.1177/1352458517730132  0.398
2017 Righart R, Biberacher V, Jonkman LE, Klaver R, Schmidt P, Buck D, Berthele A, Kirschke JS, Zimmer C, Hemmer B, Geurts JJ, Mühlau M. Cortical pathology in MS detected by the T1/T2-weighted ratio from routine MRI. Annals of Neurology. PMID 28833433 DOI: 10.1002/ana.25020  0.345
2017 Strijbis EMM, Kooi EJ, van der Valk P, Geurts JJG. Cortical Remyelination Is Heterogeneous in Multiple Sclerosis. Journal of Neuropathology and Experimental Neurology. 76: 390-401. PMID 28521040 DOI: 10.1093/jnen/nlx023  0.494
2017 Meijer KA, Eijlers AJC, Douw L, Uitdehaag BMJ, Barkhof F, Geurts JJG, Schoonheim MM. Increased connectivity of hub networks and cognitive impairment in multiple sclerosis. Neurology. PMID 28468841 DOI: 10.1212/Wnl.0000000000003982  0.418
2017 Klauser AM, Wiebenga OT, Eijlers AJ, Schoonheim MM, Uitdehaag BM, Barkhof F, Pouwels PJ, Geurts JJ. Metabolites predict lesion formation and severity in relapsing-remitting multiple sclerosis. Multiple Sclerosis (Houndmills, Basingstoke, England). 1352458517702534. PMID 28406063 DOI: 10.1177/1352458517702534  0.547
2017 Strijbis EM, Kooi EJ, van der Valk P, Geurts JJ. Cortical Remyelination Is Heterogeneous in Multiple Sclerosis. Journal of Neuropathology and Experimental Neurology. PMID 28398505 DOI: 10.1093/jnen/nlx023  0.494
2017 Eijlers AJ, Meijer KA, Wassenaar TM, Steenwijk MD, Uitdehaag BM, Barkhof F, Wink AM, Geurts JJ, Schoonheim MM. Increased default-mode network centrality in cognitively impaired multiple sclerosis patients. Neurology. PMID 28179464 DOI: 10.1212/Wnl.0000000000003689  0.46
2017 Derks J, Dirkson AR, de Witt Hamer PC, van Geest Q, Hulst HE, Barkhof F, Pouwels PJ, Geurts JJ, Reijneveld JC, Douw L. Connectomic profile and clinical phenotype in newly diagnosed glioma patients. Neuroimage. Clinical. 14: 87-96. PMID 28154795 DOI: 10.1016/J.Nicl.2017.01.007  0.357
2016 Rocca MA, Battaglini M, Benedict RH, De Stefano N, Geurts JJ, Henry RG, Horsfield MA, Jenkinson M, Pagani E, Filippi M. Brain MRI atrophy quantification in MS: From methods to clinical application. Neurology. PMID 27986875 DOI: 10.1212/Wnl.0000000000003542  0.357
2016 Michailidou I, Naessens DM, Hametner S, Guldenaar W, Kooi EJ, Geurts JJ, Baas F, Lassmann H, Ramaglia V. Complement C3 on microglial clusters in multiple sclerosis occur in chronic but not acute disease: Implication for disease pathogenesis. Glia. PMID 27778395 DOI: 10.1002/glia.23090  0.351
2016 Geurts JJ, Chard DT. Visualization of cortical MS lesions with MRI need not be further improved - YES. Multiple Sclerosis (Houndmills, Basingstoke, England). PMID 27566450 DOI: 10.1177/1352458516665498  0.425
2016 Wiebenga OT, Schoonheim MM, Hulst HE, Nagtegaal GJ, Strijbis EM, Steenwijk MD, Polman CH, Pouwels PJ, Barkhof F, Geurts JJ. White Matter Diffusion Changes during the First Year of Natalizumab Treatment in Relapsing-Remitting Multiple Sclerosis. Ajnr. American Journal of Neuroradiology. PMID 26965463 DOI: 10.3174/Ajnr.A4690  0.601
2016 Kilsdonk ID, Jonkman LE, Klaver R, van Veluw SJ, Zwanenburg JJ, Kuijer JP, Pouwels PJ, Twisk JW, Wattjes MP, Luijten PR, Barkhof F, Geurts JJ. Increased cortical grey matter lesion detection in multiple sclerosis with 7 T MRI: a post-mortem verification study. Brain : a Journal of Neurology. PMID 26956422 DOI: 10.1093/Brain/Aww037  0.463
2016 Popescu V, Klaver R, Versteeg A, Voorn P, Twisk JW, Barkhof F, Geurts JJ, Vrenken H. Postmortem validation of MRI cortical volume measurements in MS. Human Brain Mapping. PMID 26945922 DOI: 10.1002/Hbm.23168  0.474
2016 Jonkman LE, Klaver R, Fleysher L, Inglese M, Geurts JJ. The substrate of increased cortical FA in MS: A 7T post-mortem MRI and histopathology study. Multiple Sclerosis (Houndmills, Basingstoke, England). PMID 26945031 DOI: 10.1177/1352458516635290  0.499
2016 Zhang Y, Jonkman L, Klauser A, Barkhof F, Yong VW, Metz LM, Geurts JJ. Multi-scale MRI spectrum detects differences in myelin integrity between MS lesion types. Multiple Sclerosis (Houndmills, Basingstoke, England). PMID 26754802 DOI: 10.1177/1352458515624771  0.579
2016 Meijer KA, Muhlert N, Cercignani M, Sethi V, Ron MA, Thompson AJ, Miller DH, Chard D, Geurts JJ, Ciccarelli O. White matter tract abnormalities are associated with cognitive dysfunction in secondary progressive multiple sclerosis. Multiple Sclerosis (Houndmills, Basingstoke, England). PMID 26733423 DOI: 10.1177/1352458515622694  0.421
2015 Jonkman LE, Fleysher L, Steenwijk MD, Koeleman JA, de Snoo TP, Barkhof F, Inglese M, Geurts JJ. Ultra-high field MTR and qR2* differentiates subpial cortical lesions from normal-appearing gray matter in multiple sclerosis. Multiple Sclerosis (Houndmills, Basingstoke, England). PMID 26672996 DOI: 10.1177/1352458515620499  0.56
2015 Steenwijk MD, Geurts JJ, Daams M, Tijms BM, Wink AM, Balk LJ, Tewarie PK, Uitdehaag BM, Barkhof F, Vrenken H, Pouwels PJ. Cortical atrophy patterns in multiple sclerosis are non-random and clinically relevant. Brain : a Journal of Neurology. PMID 26637488 DOI: 10.1093/Brain/Awv337  0.499
2015 Steenwijk MD, Vrenken H, Jonkman LE, Daams M, Geurts JJ, Barkhof F, Pouwels PJ. High-resolution T1-relaxation time mapping displays subtle, clinically relevant, gray matter damage in long-standing multiple sclerosis. Multiple Sclerosis (Houndmills, Basingstoke, England). PMID 26564997 DOI: 10.1177/1352458515615953  0.518
2015 Jonkman LE, Klaver R, Fleysher L, Inglese M, Geurts JJ. Ultra-High-Field MRI Visualization of Cortical Multiple Sclerosis Lesions with T2 and T2*: A Postmortem MRI and Histopathology Study. Ajnr. American Journal of Neuroradiology. PMID 26228878 DOI: 10.3174/Ajnr.A4418  0.41
2015 Daams M, Steenwijk MD, Schoonheim MM, Wattjes MP, Balk LJ, Tewarie PK, Killestein J, Uitdehaag BM, Geurts JJ, Barkhof F. Multi-parametric structural magnetic resonance imaging in relation to cognitive dysfunction in long-standing multiple sclerosis. Multiple Sclerosis (Houndmills, Basingstoke, England). PMID 26209593 DOI: 10.1177/1352458515596598  0.477
2015 Prins M, Schul E, Geurts J, van der Valk P, Drukarch B, van Dam AM. Pathological differences between white and grey matter multiple sclerosis lesions. Annals of the New York Academy of Sciences. 1351: 99-113. PMID 26200258 DOI: 10.1111/Nyas.12841  0.502
2015 van Munster CE, Jonkman LE, Weinstein HC, Uitdehaag BM, Geurts JJ. Gray matter damage in multiple sclerosis: Impact on clinical symptoms. Neuroscience. 303: 446-61. PMID 26164500 DOI: 10.1016/j.neuroscience.2015.07.006  0.476
2015 Daams M, Steenwijk MD, Wattjes MP, Geurts JJ, Uitdehaag BM, Tewarie PK, Balk LJ, Pouwels PJ, Killestein J, Barkhof F. Unraveling the neuroimaging predictors for motor dysfunction in long-standing multiple sclerosis. Neurology. 85: 248-55. PMID 26115736 DOI: 10.1212/Wnl.0000000000001756  0.452
2015 Krudop WA, Bosman S, Geurts JJ, Sikkes SA, Verwey NA, Stek ML, Scheltens P, Rozemuller AJ, Pijnenburg YA. Clinico-Pathological Correlations of the Frontal Lobe Syndrome: Results of a Large Brain Bank Study. Dementia and Geriatric Cognitive Disorders. 40: 121-9. PMID 26088035 DOI: 10.1016/J.Jalz.2012.05.1659  0.315
2015 't Hart BA, van Kooyk Y, Geurts JJ, Gran B. The primate autoimmune encephalomyelitis model; a bridge between mouse and man. Annals of Clinical and Translational Neurology. 2: 581-93. PMID 26000330 DOI: 10.1002/acn3.194  0.337
2015 van de Pavert SH, Muhlert N, Sethi V, Wheeler-Kingshott CA, Ridgway GR, Geurts JJ, Ron M, Yousry TA, Thompson AJ, Miller DH, Chard DT, Ciccarelli O. DIR-visible grey matter lesions and atrophy in multiple sclerosis: partners in crime? Journal of Neurology, Neurosurgery, and Psychiatry. PMID 25926483 DOI: 10.1136/jnnp-2014-310142  0.501
2015 Klaver R, Popescu V, Voorn P, Galis-de Graaf Y, van der Valk P, de Vries HE, Schenk GJ, Geurts JJ. Neuronal and axonal loss in normal-appearing gray matter and subpial lesions in multiple sclerosis. Journal of Neuropathology and Experimental Neurology. 74: 453-8. PMID 25853695 DOI: 10.1097/Nen.0000000000000189  0.438
2015 Barkhof F, Geurts JJ. Laminar cortical damage in multiple sclerosis. Brain : a Journal of Neurology. 138: 828-9. PMID 25802316 DOI: 10.1093/Brain/Awv031  0.516
2015 Jonkman LE, Soriano AL, Amor S, Barkhof F, van der Valk P, Vrenken H, Geurts JJ. Can MS lesion stages be distinguished with MRI? A postmortem MRI and histopathology study. Journal of Neurology. 262: 1074-80. PMID 25761376 DOI: 10.1007/S00415-015-7689-4  0.578
2015 Wiebenga OT, Klauser AM, Schoonheim MM, Nagtegaal GJ, Steenwijk MD, van Rossum JA, Polman CH, Barkhof F, Pouwels PJ, Geurts JJ. Enhanced Axonal Metabolism during Early Natalizumab Treatment in Relapsing-Remitting Multiple Sclerosis. Ajnr. American Journal of Neuroradiology. 36: 1116-23. PMID 25742985 DOI: 10.3174/Ajnr.A4252  0.61
2015 Michailidou I, Willems JG, Kooi EJ, van Eden C, Gold SM, Geurts JJ, Baas F, Huitinga I, Ramaglia V. Complement C1q-C3-associated synaptic changes in multiple sclerosis hippocampus. Annals of Neurology. 77: 1007-26. PMID 25727254 DOI: 10.1002/ana.24398  0.308
2015 Calabrese M, Magliozzi R, Ciccarelli O, Geurts JJ, Reynolds R, Martin R. Exploring the origins of grey matter damage in multiple sclerosis. Nature Reviews. Neuroscience. 16: 147-58. PMID 25697158 DOI: 10.1038/Nrn3900  0.376
2015 Hulst HE, Schoonheim MM, Van Geest Q, Uitdehaag BM, Barkhof F, Geurts JJ. Memory impairment in multiple sclerosis: Relevance of hippocampal activation and hippocampal connectivity. Multiple Sclerosis (Houndmills, Basingstoke, England). PMID 25680986 DOI: 10.1177/1352458514567727  0.46
2015 Rocca MA, Amato MP, De Stefano N, Enzinger C, Geurts JJ, Penner IK, Rovira A, Sumowski JF, Valsasina P, Filippi M. Clinical and imaging assessment of cognitive dysfunction in multiple sclerosis. The Lancet. Neurology. 14: 302-17. PMID 25662900 DOI: 10.1016/S1474-4422(14)70250-9  0.402
2015 Steenwijk MD, Daams M, Pouwels PJ, J Balk L, Tewarie PK, Geurts JJ, Barkhof F, Vrenken H. Unraveling the relationship between regional gray matter atrophy and pathology in connected white matter tracts in long-standing multiple sclerosis. Human Brain Mapping. 36: 1796-807. PMID 25627545 DOI: 10.1002/Hbm.22738  0.539
2015 Schoonheim MM, Hulst HE, Brandt RB, Strik M, Wink AM, Uitdehaag BM, Barkhof F, Geurts JJ. Thalamus structure and function determine severity of cognitive impairment in multiple sclerosis. Neurology. 84: 776-83. PMID 25616483 DOI: 10.1212/Wnl.0000000000001285  0.486
2015 Popescu V, Klaver R, Voorn P, Galis-de Graaf Y, Knol D, Twisk J, Versteeg A, Schenk G, Van der Valk P, Barkhof F, De Vries H, Vrenken H, Geurts J. What drives MRI-measured cortical atrophy in multiple sclerosis? Multiple Sclerosis (Houndmills, Basingstoke, England). PMID 25583833 DOI: 10.1177/1352458514562440  0.517
2015 Tewarie P, Schoonheim MM, Schouten DI, Polman CH, Balk LJ, Uitdehaag BM, Geurts JJ, Hillebrand A, Barkhof F, Stam CJ. Functional brain networks: linking thalamic atrophy to clinical disability in multiple sclerosis, a multimodal fMRI and MEG study. Human Brain Mapping. 36: 603-18. PMID 25293505 DOI: 10.1002/Hbm.22650  0.616
2015 Kilsdonk ID, Steenwijk MD, Pouwels PJ, Zwanenburg JJ, Visser F, Luijten PR, Geurts J, Barkhof F, Wattjes MP. Perivascular spaces in MS patients at 7 Tesla MRI: a marker of neurodegeneration? Multiple Sclerosis (Houndmills, Basingstoke, England). 21: 155-62. PMID 25013150 DOI: 10.1177/1352458514540358  0.504
2015 Lukas C, Knol DL, Sombekke MH, Bellenberg B, Hahn HK, Popescu V, Weier K, Radue EW, Gass A, Kappos L, Naegelin Y, Uitdehaag BM, Geurts JJ, Barkhof F, Vrenken H. Cervical spinal cord volume loss is related to clinical disability progression in multiple sclerosis. Journal of Neurology, Neurosurgery, and Psychiatry. 86: 410-8. PMID 24973341 DOI: 10.1136/Jnnp-2014-308021  0.449
2015 Poon KW, Brideau C, Schenk GJ, Klaver R, Klauser AM, Kawasoe JH, Geurts JJG, Stys PK. Quantitative biochemical investigation of various neuropathologies using high-resolution spectral CARS microscopy Progress in Biomedical Optics and Imaging - Proceedings of Spie. 9305. DOI: 10.1117/12.2076654  0.438
2014 Tewarie P, Steenwijk MD, Tijms BM, Daams M, Balk LJ, Stam CJ, Uitdehaag BM, Polman CH, Geurts JJ, Barkhof F, Pouwels PJ, Vrenken H, Hillebrand A. Disruption of structural and functional networks in long-standing multiple sclerosis. Human Brain Mapping. 35: 5946-61. PMID 25053254 DOI: 10.1002/Hbm.22596  0.616
2014 Daams M, Weiler F, Steenwijk MD, Hahn HK, Geurts JJ, Vrenken H, van Schijndel RA, Balk LJ, Tewarie PK, Tillema JM, Killestein J, Uitdehaag BM, Barkhof F. Mean upper cervical cord area (MUCCA) measurement in long-standing multiple sclerosis: relation to brain findings and clinical disability. Multiple Sclerosis (Houndmills, Basingstoke, England). 20: 1860-5. PMID 24812042 DOI: 10.1177/1352458514533399  0.427
2014 Kilsdonk ID, Lopez-Soriano A, Kuijer JP, de Graaf WL, Castelijns JA, Polman CH, Luijten PR, Geurts JJ, Barkhof F, Wattjes MP. Morphological features of MS lesions on FLAIR* at 7 T and their relation to patient characteristics. Journal of Neurology. 261: 1356-64. PMID 24777693 DOI: 10.1007/S00415-014-7351-6  0.769
2014 Steenwijk MD, Daams M, Pouwels PJ, Balk LJ, Tewarie PK, Killestein J, Uitdehaag BM, Geurts JJ, Barkhof F, Vrenken H. What explains gray matter atrophy in long-standing multiple sclerosis? Radiology. 272: 832-42. PMID 24761837 DOI: 10.1148/Radiol.14132708  0.537
2014 Muhlert N, Atzori M, De Vita E, Thomas DL, Samson RS, Wheeler-Kingshott CA, Geurts JJ, Miller DH, Thompson AJ, Ciccarelli O. Memory in multiple sclerosis is linked to glutamate concentration in grey matter regions. Journal of Neurology, Neurosurgery, and Psychiatry. 85: 833-9. PMID 24431465 DOI: 10.1136/Jnnp-2013-306662  0.362
2014 Wiebenga OT, Klauser AM, Nagtegaal GJ, Schoonheim MM, Barkhof F, Geurts JJ, Pouwels PJ. Longitudinal absolute metabolite quantification of white and gray matter regions in healthy controls using proton MR spectroscopic imaging. Nmr in Biomedicine. 27: 304-11. PMID 24399803 DOI: 10.1002/Nbm.3063  0.384
2014 Kilsdonk ID, Wattjes MP, Lopez-Soriano A, Kuijer JP, de Jong MC, de Graaf WL, Conijn MM, Polman CH, Luijten PR, Geurts JJ, Geerlings MI, Barkhof F. Improved differentiation between MS and vascular brain lesions using FLAIR* at 7 Tesla. European Radiology. 24: 841-9. PMID 24317461 DOI: 10.1007/S00330-013-3080-Y  0.698
2014 Tewarie P, Hillebrand A, Schoonheim MM, van Dijk BW, Geurts JJ, Barkhof F, Polman CH, Stam CJ. Functional brain network analysis using minimum spanning trees in Multiple Sclerosis: an MEG source-space study. Neuroimage. 88: 308-18. PMID 24161625 DOI: 10.1016/J.Neuroimage.2013.10.022  0.598
2014 Schoonheim MM, Vigeveno RM, Rueda Lopes FC, Pouwels PJ, Polman CH, Barkhof F, Geurts JJ. Sex-specific extent and severity of white matter damage in multiple sclerosis: implications for cognitive decline. Human Brain Mapping. 35: 2348-58. PMID 23982918 DOI: 10.1002/Hbm.22332  0.611
2014 Kearney H, Rocca MA, Valsasina P, Balk L, Sastre-Garriga J, Reinhardt J, Ruggieri S, Rovira A, Stippich C, Kappos L, Sprenger T, Tortorella P, Rovaris M, Gasperini C, Montalban X, ... Geurts JJ, et al. Magnetic resonance imaging correlates of physical disability in relapse onset multiple sclerosis of long disease duration. Multiple Sclerosis (Houndmills, Basingstoke, England). 20: 72-80. PMID 23812283 DOI: 10.1177/1352458513492245  0.646
2014 Bruinsma I, Eijsink V, Kooi EJ, Baranzini S, Ji XH, Axtell R, Han M, Kuipers H, Sobel R, Polman C, Geurts J, Martens GJM, Poelmans G, Steinman L, Jong BD. Genome-wide RNA expression profiling in human grey and white matter tissue reveals a role for PSA-NCAM dysregulation in MS pathogenesis Journal of Neuroimmunology. 275: 180-181. DOI: 10.1016/J.Jneuroim.2014.08.485  0.549
2013 Schoonheim M, Geurts J, Wiebenga O, De Munck J, Polman C, Stam C, Barkhof F, Wink A. Changes in functional network centrality underlie cognitive dysfunction and physical disability in multiple sclerosis. Multiple Sclerosis (Houndmills, Basingstoke, England). 20: 1058-1065. PMID 24347184 DOI: 10.1177/1352458513516892  0.605
2013 Hulst HE, Gehring K, Uitdehaag BM, Visser LH, Polman CH, Barkhof F, Sitskoorn MM, Geurts JJ. Indicators for cognitive performance and subjective cognitive complaints in multiple sclerosis: a role for advanced MRI? Multiple Sclerosis (Houndmills, Basingstoke, England). 20: 1131-1134. PMID 24277326 DOI: 10.1177/1352458513513969  0.612
2013 Daams M, Geurts JJ, Barkhof F. Cortical imaging in multiple sclerosis: recent findings and 'grand challenges'. Current Opinion in Neurology. 26: 345-52. PMID 23812306 DOI: 10.1097/Wco.0B013E328362A864  0.555
2013 Lukas C, Sombekke MH, Bellenberg B, Hahn HK, Popescu V, Bendfeldt K, Radue EW, Gass A, Borgwardt SJ, Kappos L, Naegelin Y, Knol DL, Polman CH, Geurts JJ, Barkhof F, et al. Relevance of spinal cord abnormalities to clinical disability in multiple sclerosis: MR imaging findings in a large cohort of patients. Radiology. 269: 542-52. PMID 23737540 DOI: 10.1148/Radiol.13122566  0.664
2013 Hulst HE, Steenwijk MD, Versteeg A, Pouwels PJ, Vrenken H, Uitdehaag BM, Polman CH, Geurts JJ, Barkhof F. Cognitive impairment in MS: impact of white matter integrity, gray matter volume, and lesions. Neurology. 80: 1025-32. PMID 23468546 DOI: 10.1212/Wnl.0B013E31828726Cc  0.66
2013 Filippi M, Rocca MA, Horsfield MA, Hametner S, Geurts JJ, Comi G, Lassmann H. Imaging cortical damage and dysfunction in multiple sclerosis. Jama Neurology. 70: 556-64. PMID 23460023 DOI: 10.1001/jamaneurol.2013.1954  0.37
2013 Benedict RH, Hulst HE, Bergsland N, Schoonheim MM, Dwyer MG, Weinstock-Guttman B, Geurts JJ, Zivadinov R. Clinical significance of atrophy and white matter mean diffusivity within the thalamus of multiple sclerosis patients. Multiple Sclerosis (Houndmills, Basingstoke, England). 19: 1478-84. PMID 23459570 DOI: 10.1177/1352458513478675  0.4
2013 Klaver R, De Vries HE, Schenk GJ, Geurts JJ. Grey matter damage in multiple sclerosis: a pathology perspective. Prion. 7: 66-75. PMID 23324595 DOI: 10.4161/pri.23499  0.475
2013 Vrenken H, Jenkinson M, Horsfield MA, Battaglini M, van Schijndel RA, Rostrup E, Geurts JJ, Fisher E, Zijdenbos A, Ashburner J, Miller DH, Filippi M, Fazekas F, Rovaris M, Rovira A, et al. Recommendations to improve imaging and analysis of brain lesion load and atrophy in longitudinal studies of multiple sclerosis. Journal of Neurology. 260: 2458-71. PMID 23263472 DOI: 10.1007/S00415-012-6762-5  0.551
2013 Kilsdonk ID, de Graaf WL, Soriano AL, Zwanenburg JJ, Visser F, Kuijer JP, Geurts JJ, Pouwels PJ, Polman CH, Castelijns JA, Luijten PR, Barkhof F, Wattjes MP. Multicontrast MR imaging at 7T in multiple sclerosis: highest lesion detection in cortical gray matter with 3D-FLAIR. Ajnr. American Journal of Neuroradiology. 34: 791-6. PMID 23042930 DOI: 10.3174/Ajnr.A3289  0.714
2013 de Graaf WL, Kilsdonk ID, Lopez-Soriano A, Zwanenburg JJ, Visser F, Polman CH, Castelijns JA, Geurts JJ, Pouwels PJ, Luijten PR, Barkhof F, Wattjes MP. Clinical application of multi-contrast 7-T MR imaging in multiple sclerosis: increased lesion detection compared to 3 T confined to grey matter. European Radiology. 23: 528-40. PMID 22898935 DOI: 10.1007/S00330-012-2619-7  0.738
2013 Inkster B, Strijbis EM, Vounou M, Kappos L, Radue EW, Matthews PM, Uitdehaag BM, Barkhof F, Polman CH, Montana G, Geurts JJ. Histone deacetylase gene variants predict brain volume changes in multiple sclerosis. Neurobiology of Aging. 34: 238-47. PMID 22884548 DOI: 10.1016/J.Neurobiolaging.2012.07.007  0.606
2013 Strijbis EM, Inkster B, Vounou M, Naegelin Y, Kappos L, Radue EW, Matthews PM, Uitdehaag BM, Barkhof F, Polman CH, Montana G, Geurts JJ. Glutamate gene polymorphisms predict brain volumes in multiple sclerosis. Multiple Sclerosis (Houndmills, Basingstoke, England). 19: 281-8. PMID 22851457 DOI: 10.1177/1352458512454345  0.621
2013 Schoonheim MM, Geurts JJ, Landi D, Douw L, van der Meer ML, Vrenken H, Polman CH, Barkhof F, Stam CJ. Functional connectivity changes in multiple sclerosis patients: a graph analytical study of MEG resting state data. Human Brain Mapping. 34: 52-61. PMID 21954106 DOI: 10.1002/Hbm.21424  0.652
2013 Poon KW, Brideau C, Teo W, Schenk GJ, Klaver R, Klauser AM, Kawasoe JH, Geurts JJG, Stys PK. Investigation of human multiple sclerosis lesions using high resolution spectrally unmixed CARS microscopy Progress in Biomedical Optics and Imaging - Proceedings of Spie. 8565. DOI: 10.1117/12.2005504  0.45
2012 Geurts JJ, Calabrese M, Fisher E, Rudick RA. Measurement and clinical effect of grey matter pathology in multiple sclerosis. The Lancet. Neurology. 11: 1082-92. PMID 23153407 DOI: 10.1016/S1474-4422(12)70230-2  0.445
2012 Schoonheim MM, Popescu V, Rueda Lopes FC, Wiebenga OT, Vrenken H, Douw L, Polman CH, Geurts JJ, Barkhof F. Subcortical atrophy and cognition: sex effects in multiple sclerosis. Neurology. 79: 1754-61. PMID 23019265 DOI: 10.1212/Wnl.0B013E3182703F46  0.6
2012 Tomassini V, Matthews PM, Thompson AJ, Fuglø D, Geurts JJ, Johansen-Berg H, Jones DK, Rocca MA, Wise RG, Barkhof F, Palace J. Neuroplasticity and functional recovery in multiple sclerosis. Nature Reviews. Neurology. 8: 635-46. PMID 22986429 DOI: 10.1038/Nrneurol.2012.179  0.391
2012 Kooi EJ, Strijbis EM, van der Valk P, Geurts JJ. Heterogeneity of cortical lesions in multiple sclerosis: clinical and pathologic implications. Neurology. 79: 1369-76. PMID 22972651 DOI: 10.1212/WNL.0b013e31826c1b1c  0.384
2012 Hardmeier M, Schoonheim MM, Geurts JJ, Hillebrand A, Polman CH, Barkhof F, Stam CJ. Cognitive dysfunction in early multiple sclerosis: altered centrality derived from resting-state functional connectivity using magneto-encephalography. Plos One. 7: e42087. PMID 22848712 DOI: 10.1371/Journal.Pone.0042087  0.582
2012 van Horssen J, Singh S, van der Pol S, Kipp M, Lim JL, Peferoen L, Gerritsen W, Kooi EJ, Witte ME, Geurts JJ, de Vries HE, Peferoen-Baert R, van den Elsen PJ, van der Valk P, Amor S. Clusters of activated microglia in normal-appearing white matter show signs of innate immune activation. Journal of Neuroinflammation. 9: 156. PMID 22747960 DOI: 10.1186/1742-2094-9-156  0.421
2012 Stys PK, Zamponi GW, van Minnen J, Geurts JJ. Will the real multiple sclerosis please stand up? Nature Reviews. Neuroscience. 13: 507-14. PMID 22714021 DOI: 10.1038/Nrn3275  0.375
2012 Vigeveno RM, Wiebenga OT, Wattjes MP, Geurts JJ, Barkhof F. Shifting imaging targets in multiple sclerosis: from inflammation to neurodegeneration. Journal of Magnetic Resonance Imaging : Jmri. 36: 1-19. PMID 22696123 DOI: 10.1002/Jmri.23578  0.527
2012 Geurts JJ. The neurologist's dilemma: MS is a grey matter disease that standard clinical and MRI measures cannot assess adequately--yes. Multiple Sclerosis (Houndmills, Basingstoke, England). 18: 559-60. PMID 22547412 DOI: 10.1177/1352458512443997  0.372
2012 Filippi M, Rocca MA, Barkhof F, Brück W, Chen JT, Comi G, DeLuca G, De Stefano N, Erickson BJ, Evangelou N, Fazekas F, Geurts JJ, Lucchinetti C, Miller DH, Pelletier D, et al. Association between pathological and MRI findings in multiple sclerosis. The Lancet. Neurology. 11: 349-60. PMID 22441196 DOI: 10.1016/S1474-4422(12)70003-0  0.575
2012 Seewann A, Kooi EJ, Roosendaal SD, Pouwels PJ, Wattjes MP, van der Valk P, Barkhof F, Polman CH, Geurts JJ. Postmortem verification of MS cortical lesion detection with 3D DIR. Neurology. 78: 302-8. PMID 22218278 DOI: 10.1212/Wnl.0B013E31824528A0  0.628
2012 Schoonheim MM, Hulst HE, Landi D, Ciccarelli O, Roosendaal SD, Sanz-Arigita EJ, Vrenken H, Polman CH, Stam CJ, Barkhof F, Geurts JJ. Gender-related differences in functional connectivity in multiple sclerosis. Multiple Sclerosis (Houndmills, Basingstoke, England). 18: 164-73. PMID 21908484 DOI: 10.1177/1352458511422245  0.606
2012 Hulst HE, Schoonheim MM, Roosendaal SD, Popescu V, Schweren LJ, van der Werf YD, Visser LH, Polman CH, Barkhof F, Geurts JJ. Functional adaptive changes within the hippocampal memory system of patients with multiple sclerosis. Human Brain Mapping. 33: 2268-80. PMID 21898674 DOI: 10.1002/Hbm.21359  0.606
2012 de Graaf WL, Zwanenburg JJ, Visser F, Wattjes MP, Pouwels PJ, Geurts JJ, Polman CH, Barkhof F, Luijten PR, Castelijns JA. Lesion detection at seven Tesla in multiple sclerosis using magnetisation prepared 3D-FLAIR and 3D-DIR. European Radiology. 22: 221-31. PMID 21874361 DOI: 10.1007/S00330-011-2242-Z  0.694
2012 Bendfeldt K, Hofstetter L, Kuster P, Traud S, Mueller-Lenke N, Naegelin Y, Kappos L, Gass A, Nichols TE, Barkhof F, Vrenken H, Roosendaal SD, Geurts JJ, Radue EW, Borgwardt SJ. Longitudinal gray matter changes in multiple sclerosis--differential scanner and overall disease-related effects. Human Brain Mapping. 33: 1225-45. PMID 21538703 DOI: 10.1002/Hbm.21279  0.517
2011 Hulst HE, Geurts JJ. Gray matter imaging in multiple sclerosis: what have we learned? Bmc Neurology. 11: 153. PMID 22152037 DOI: 10.1186/1471-2377-11-153  0.474
2011 Kooi EJ, Prins M, Bajic N, Beliën JA, Gerritsen WH, van Horssen J, Aronica E, van Dam AM, Hoozemans JJ, Francis PT, van der Valk P, Geurts JJ. Cholinergic imbalance in the multiple sclerosis hippocampus. Acta Neuropathologica. 122: 313-22. PMID 21691765 DOI: 10.1007/s00401-011-0849-4  0.321
2011 Chard DT, Geurts JJ. Predicting the development of multiple sclerosis: is gray matter a missing piece of the puzzle? Neurology. 77: 210-1. PMID 21613598 DOI: 10.1212/WNL.0b013e318220ac31  0.315
2011 Sombekke MH, Jafari N, Bendfeldt K, Mueller-Lenke N, Radue EW, Naegelin Y, Kappos L, Matthews PM, Polman CH, Barkhof F, Hintzen R, Geurts JJ. No influence of KIF1B on neurodegenerative markers in multiple sclerosis. Neurology. 76: 1843-5. PMID 21606458 DOI: 10.1212/Wnl.0B013E31821Cccd4  0.632
2011 Roosendaal SD, Bendfeldt K, Vrenken H, Polman CH, Borgwardt S, Radue EW, Kappos L, Pelletier D, Hauser SL, Matthews PM, Barkhof F, Geurts JJ. Grey matter volume in a large cohort of MS patients: relation to MRI parameters and disability. Multiple Sclerosis (Houndmills, Basingstoke, England). 17: 1098-106. PMID 21586487 DOI: 10.1177/1352458511404916  0.656
2011 Seewann A, Vrenken H, Kooi EJ, van der Valk P, Knol DL, Polman CH, Pouwels PJ, Barkhof F, Geurts JJ. Imaging the tip of the iceberg: visualization of cortical lesions in multiple sclerosis. Multiple Sclerosis (Houndmills, Basingstoke, England). 17: 1202-10. PMID 21561955 DOI: 10.1177/1352458511406575  0.679
2011 Sombekke MH, Vellinga MM, Uitdehaag BM, Barkhof F, Polman CH, Arteta D, Tejedor D, Martinez A, Crusius JB, Peña AS, Geurts JJ, Vrenken H. Genetic correlations of brain lesion distribution in multiple sclerosis: an exploratory study. Ajnr. American Journal of Neuroradiology. 32: 695-703. PMID 21436341 DOI: 10.3174/Ajnr.A2352  0.638
2011 Geurts JJ, Roosendaal SD, Calabrese M, Ciccarelli O, Agosta F, Chard DT, Gass A, Huerga E, Moraal B, Pareto D, Rocca MA, Wattjes MP, Yousry TA, Uitdehaag BM, Barkhof F, et al. Consensus recommendations for MS cortical lesion scoring using double inversion recovery MRI. Neurology. 76: 418-24. PMID 21209373 DOI: 10.1212/Wnl.0B013E31820A0Cc4  0.555
2011 van Noort JM, van den Elsen PJ, van Horssen J, Geurts JJ, van der Valk P, Amor S. Preactive multiple sclerosis lesions offer novel clues for neuroprotective therapeutic strategies. Cns & Neurological Disorders Drug Targets. 10: 68-81. PMID 21143143 DOI: 10.2174/187152711794488566  0.439
2011 Gouw AA, Seewann A, van der Flier WM, Barkhof F, Rozemuller AM, Scheltens P, Geurts JJ. Heterogeneity of small vessel disease: a systematic review of MRI and histopathology correlations. Journal of Neurology, Neurosurgery, and Psychiatry. 82: 126-35. PMID 20935330 DOI: 10.1136/Jnnp.2009.204685  0.44
2011 Wattjes MP, Geurts JJG, Barkhof F. Imaging of gray matter lesions in multiple sclerosis Multiple Sclerosis Therapeutics, Fourth Edition. 165-174. DOI: 10.1017/CBO9781139023986.016  0.553
2010 Filippi M, Rocca MA, Benedict RH, DeLuca J, Geurts JJ, Rombouts SA, Ron M, Comi G. The contribution of MRI in assessing cognitive impairment in multiple sclerosis. Neurology. 75: 2121-8. PMID 21135387 DOI: 10.1212/Wnl.0B013E318200D768  0.426
2010 Coebergh JA, Roosendaal SD, Polman CH, Geurts JJ, van Woerkom TC. Acute severe memory impairment as a presenting symptom of multiple sclerosis: a clinical case study with 3D double inversion recovery MR imaging. Multiple Sclerosis (Houndmills, Basingstoke, England). 16: 1521-4. PMID 20846999 DOI: 10.1177/1352458510383302  0.571
2010 Geurts JJ, Vrenken H. Toward understanding cortical lesions in multiple sclerosis. Neurology. 75: 1224-5. PMID 20739643 DOI: 10.1212/WNL.0b013e3181f5d4f1  0.418
2010 Moraal B, van den Elskamp IJ, Knol DL, Uitdehaag BM, Geurts JJ, Vrenken H, Pouwels PJ, van Schijndel RA, Meier DS, Guttmann CR, Barkhof F. Long-interval T2-weighted subtraction magnetic resonance imaging: a powerful new outcome measure in multiple sclerosis trials. Annals of Neurology. 67: 667-75. PMID 20437564 DOI: 10.1002/Ana.21958  0.459
2010 Roosendaal SD, Hulst HE, Vrenken H, Feenstra HE, Castelijns JA, Pouwels PJ, Barkhof F, Geurts JJ. Structural and functional hippocampal changes in multiple sclerosis patients with intact memory function. Radiology. 255: 595-604. PMID 20413769 DOI: 10.1148/Radiol.10091433  0.676
2010 Schoonheim MM, Geurts JJ, Barkhof F. The limits of functional reorganization in multiple sclerosis. Neurology. 74: 1246-7. PMID 20404304 DOI: 10.1212/Wnl.0B013E3181Db9957  0.394
2010 Roosendaal SD, Schoonheim MM, Hulst HE, Sanz-Arigita EJ, Smith SM, Geurts JJ, Barkhof F. Resting state networks change in clinically isolated syndrome. Brain : a Journal of Neurology. 133: 1612-21. PMID 20356855 DOI: 10.1093/Brain/Awq058  0.478
2010 Moraal B, Wattjes MP, Geurts JJ, Knol DL, van Schijndel RA, Pouwels PJ, Vrenken H, Barkhof F. Improved detection of active multiple sclerosis lesions: 3D subtraction imaging. Radiology. 255: 154-63. PMID 20308453 DOI: 10.1148/Radiol.09090814  0.524
2010 Simon B, Schmidt S, Lukas C, Gieseke J, Träber F, Knol DL, Willinek WA, Geurts JJ, Schild HH, Barkhof F, Wattjes MP. Improved in vivo detection of cortical lesions in multiple sclerosis using double inversion recovery MR imaging at 3 Tesla. European Radiology. 20: 1675-83. PMID 20094887 DOI: 10.1007/S00330-009-1705-Y  0.54
2010 Torkildsen Ø, Stansberg C, AngelskÃ¥r SM, Kooi EJ, Geurts JJ, van der Valk P, Myhr KM, Steen VM, Bø L. Upregulation of immunoglobulin-related genes in cortical sections from multiple sclerosis patients. Brain Pathology (Zurich, Switzerland). 20: 720-9. PMID 19919606 DOI: 10.1111/J.1750-3639.2009.00343.X  0.358
2010 Vrenken H, Seewann A, Knol DL, Polman CH, Barkhof F, Geurts JJ. Diffusely abnormal white matter in progressive multiple sclerosis: in vivo quantitative MR imaging characterization and comparison between disease types. Ajnr. American Journal of Neuroradiology. 31: 541-8. PMID 19850760 DOI: 10.3174/Ajnr.A1839  0.69
2009 Sombekke MH, Lukas C, Crusius JB, Tejedor D, Killestein J, Arteta D, Martínez A, Uitdehaag BM, Knol DL, Peña AS, Geurts JJ, De Jager PL, Barkhof F, Vrenken H, Polman CH. HLA-DRB1*1501 and spinal cord magnetic resonance imaging lesions in multiple sclerosis. Archives of Neurology. 66: 1531-6. PMID 20008659 DOI: 10.1001/Archneurol.2009.278  0.594
2009 Kooi EJ, Geurts JJ, van Horssen J, Bø L, van der Valk P. Meningeal inflammation is not associated with cortical demyelination in chronic multiple sclerosis. Journal of Neuropathology and Experimental Neurology. 68: 1021-8. PMID 19680141 DOI: 10.1097/NEN.0b013e3181b4bf8f  0.467
2009 Wattjes MP, Henneman WJ, van der Flier WM, de Vries O, Träber F, Geurts JJ, Scheltens P, Vrenken H, Barkhof F. Diagnostic imaging of patients in a memory clinic: comparison of MR imaging and 64-detector row CT. Radiology. 253: 174-83. PMID 19635835 DOI: 10.1148/Radiol.2531082262  0.369
2009 Witte ME, Bø L, Rodenburg RJ, Belien JA, Musters R, Hazes T, Wintjes LT, Smeitink JA, Geurts JJ, De Vries HE, van der Valk P, van Horssen J. Enhanced number and activity of mitochondria in multiple sclerosis lesions. The Journal of Pathology. 219: 193-204. PMID 19591199 DOI: 10.1002/path.2582  0.378
2009 Kooi EJ, van Horssen J, Witte ME, Amor S, Bø L, Dijkstra CD, van der Valk P, Geurts JJ. Abundant extracellular myelin in the meninges of patients with multiple sclerosis. Neuropathology and Applied Neurobiology. 35: 283-95. PMID 19473295 DOI: 10.1111/j.1365-2990.2008.00986.x  0.368
2009 Roosendaal SD, Moraal B, Pouwels PJ, Vrenken H, Castelijns JA, Barkhof F, Geurts JJ. Accumulation of cortical lesions in MS: relation with cognitive impairment. Multiple Sclerosis (Houndmills, Basingstoke, England). 15: 708-14. PMID 19435749 DOI: 10.1177/1352458509102907  0.708
2009 Seewann A, Vrenken H, van der Valk P, Blezer EL, Knol DL, Castelijns JA, Polman CH, Pouwels PJ, Barkhof F, Geurts JJ. Diffusely abnormal white matter in chronic multiple sclerosis: imaging and histopathologic analysis. Archives of Neurology. 66: 601-9. PMID 19433660 DOI: 10.1001/Archneurol.2009.57  0.768
2009 Vellinga MM, Vrenken H, Hulst HE, Polman CH, Uitdehaag BM, Pouwels PJ, Barkhof F, Geurts JJ. Use of ultrasmall superparamagnetic particles of iron oxide (USPIO)-enhanced MRI to demonstrate diffuse inflammation in the normal-appearing white matter (NAWM) of multiple sclerosis (MS) patients: an exploratory study. Journal of Magnetic Resonance Imaging : Jmri. 29: 774-9. PMID 19306366 DOI: 10.1002/Jmri.21678  0.694
2009 Vellinga MM, Geurts JJ, Rostrup E, Uitdehaag BM, Polman CH, Barkhof F, Vrenken H. Clinical correlations of brain lesion distribution in multiple sclerosis. Journal of Magnetic Resonance Imaging : Jmri. 29: 768-73. PMID 19306365 DOI: 10.1002/Jmri.21679  0.678
2009 Seewann A, Kooi EJ, Roosendaal SD, Barkhof F, van der Valk P, Geurts JJ. Translating pathology in multiple sclerosis: the combination of postmortem imaging, histopathology and clinical findings. Acta Neurologica Scandinavica. 119: 349-55. PMID 19254283 DOI: 10.1111/J.1600-0404.2008.01137.X  0.521
2009 Geurts JJ, Stys PK, Minagar A, Amor S, Zivadinov R. Gray matter pathology in (chronic) MS: modern views on an early observation. Journal of the Neurological Sciences. 282: 12-20. PMID 19249061 DOI: 10.1016/J.Jns.2009.01.018  0.506
2009 Moraal B, Meier DS, Poppe PA, Geurts JJ, Vrenken H, Jonker WM, Knol DL, van Schijndel RA, Pouwels PJ, Pohl C, Bauer L, Sandbrink R, Guttmann CR, Barkhof F. Subtraction MR images in a multiple sclerosis multicenter clinical trial setting. Radiology. 250: 506-14. PMID 19037018 DOI: 10.1148/Radiol.2501080480  0.524
2009 Roosendaal SD, Geurts JJ, Vrenken H, Hulst HE, Cover KS, Castelijns JA, Pouwels PJ, Barkhof F. Regional DTI differences in multiple sclerosis patients. Neuroimage. 44: 1397-403. PMID 19027076 DOI: 10.1016/J.Neuroimage.2008.10.026  0.703
2009 Baranzini SE, Wang J, Gibson RA, Galwey N, Naegelin Y, Barkhof F, Radue EW, Lindberg RL, Uitdehaag BM, Johnson MR, Angelakopoulou A, Hall L, Richardson JC, Prinjha RK, Gass A, ... Geurts JJ, et al. Genome-wide association analysis of susceptibility and clinical phenotype in multiple sclerosis. Human Molecular Genetics. 18: 767-78. PMID 19010793 DOI: 10.1093/Hmg/Ddn388  0.618
2009 Gilmore CP, Geurts JJ, Evangelou N, Bot JC, van Schijndel RA, Pouwels PJ, Barkhof F, Bö L. Spinal cord grey matter lesions in multiple sclerosis detected by post-mortem high field MR imaging. Multiple Sclerosis (Houndmills, Basingstoke, England). 15: 180-8. PMID 18845658 DOI: 10.1177/1352458508096876  0.543
2008 Gouw AA, Seewann A, Vrenken H, van der Flier WM, Rozemuller JM, Barkhof F, Scheltens P, Geurts JJ. Heterogeneity of white matter hyperintensities in Alzheimer's disease: post-mortem quantitative MRI and neuropathology. Brain : a Journal of Neurology. 131: 3286-98. PMID 18927145 DOI: 10.1093/Brain/Awn265  0.441
2008 Geurts JJ. Is progressive multiple sclerosis a gray matter disease? Annals of Neurology. 64: 230-2. PMID 18825672 DOI: 10.1002/ana.21485  0.338
2008 Geurts JJ, Barkhof F. Grey matter pathology in multiple sclerosis. The Lancet. Neurology. 7: 841-51. PMID 18703006 DOI: 10.1016/S1474-4422(08)70191-1  0.546
2008 Moraal B, Roosendaal SD, Pouwels PJ, Vrenken H, van Schijndel RA, Meier DS, Guttmann CR, Geurts JJ, Barkhof F. Multi-contrast, isotropic, single-slab 3D MR imaging in multiple sclerosis. European Radiology. 18: 2311-20. PMID 18509658 DOI: 10.1177/19714009090220S108  0.468
2008 Boer K, Troost D, Jansen F, Nellist M, van den Ouweland AM, Geurts JJ, Spliet WG, Crino P, Aronica E. Clinicopathological and immunohistochemical findings in an autopsy case of tuberous sclerosis complex. Neuropathology : Official Journal of the Japanese Society of Neuropathology. 28: 577-90. PMID 18410267 DOI: 10.1111/J.1440-1789.2008.00920.X  0.367
2008 Roosendaal SD, Moraal B, Vrenken H, Castelijns JA, Pouwels PJ, Barkhof F, Geurts JJ. In vivo MR imaging of hippocampal lesions in multiple sclerosis. Journal of Magnetic Resonance Imaging : Jmri. 27: 726-31. PMID 18302199 DOI: 10.1002/Jmri.21294  0.722
2008 Vellinga MM, Oude Engberink RD, Seewann A, Pouwels PJ, Wattjes MP, van der Pol SM, Pering C, Polman CH, de Vries HE, Geurts JJ, Barkhof F. Pluriformity of inflammation in multiple sclerosis shown by ultra-small iron oxide particle enhancement. Brain : a Journal of Neurology. 131: 800-7. PMID 18245785 DOI: 10.1093/Brain/Awn009  0.642
2008 Geurts JJ, Blezer EL, Vrenken H, van der Toorn A, Castelijns JA, Polman CH, Pouwels PJ, Bö L, Barkhof F. Does high-field MR imaging improve cortical lesion detection in multiple sclerosis? Journal of Neurology. 255: 183-91. PMID 18231704 DOI: 10.1007/S00415-008-0620-5  0.744
2008 Wattjes MP, Vrenken H, van der Flier WM, Geurts JJ, Gillissen F, Romkes R, Scheltens P, Barkhof F. P1-307: Assessment of global cortical atrophy and medial temporal lobe atrophy in suspected and definite dementia: Comparison of magnetic resonance imaging and 64 multidetector row computed tomography Alzheimer's & Dementia. 4: T310-T310. DOI: 10.1016/j.jalz.2008.05.898  0.355
2008 Gouw AA, Seewann A, Vrenken H, van der Flier WM, Rozemuller AM, Barkhof F, Scheltens P, Geurts JJ. IC-02-04: White matter hyperintensities in Alzheimer patients and non-demented elderly: Postmortem quantitative MRI and neuropathological characteristics Alzheimer's & Dementia. 4: T5-T5. DOI: 10.1016/J.Jalz.2008.05.2484  0.386
2008 Wattjes MP, Vrenken H, van der Flier WM, Geurts JJ, Gillissen F, Romkes R, Scheltens P, Barkhof F. IC-P3-229: Assessment of global cortical atrophy and medial temporal lobe atrophy in suspected and definite dementia: Comparison of magnetic resonance imaging and 64 multi-detector row computed tomography Alzheimer's & Dementia. 4: T97-T97. DOI: 10.1016/J.Jalz.2008.05.174  0.308
2007 Geurts JJ, Bö L, Roosendaal SD, Hazes T, Daniëls R, Barkhof F, Witter MP, Huitinga I, van der Valk P. Extensive hippocampal demyelination in multiple sclerosis. Journal of Neuropathology and Experimental Neurology. 66: 819-27. PMID 17805012 DOI: 10.1097/Nen.0B013E3181461F54  0.57
2007 Vrenken H, Pouwels PJ, Ropele S, Knol DL, Geurts JJ, Polman CH, Barkhof F, Castelijns JA. Magnetization transfer ratio measurement in multiple sclerosis normal-appearing brain tissue: limited differences with controls but relationships with clinical and MR measures of disease. Multiple Sclerosis (Houndmills, Basingstoke, England). 13: 708-16. PMID 17613597 DOI: 10.1177/1352458506075521  0.771
2007 Kalkers NF, Strijers RL, Jasperse MM, Neacsu V, Geurts JJ, Barkhof F, Polman CH, Stam CJ. Motor evoked potential: a reliable and objective measure to document the functional consequences of multiple sclerosis? Relation to disability and MRI. Clinical Neurophysiology : Official Journal of the International Federation of Clinical Neurophysiology. 118: 1332-40. PMID 17398151 DOI: 10.1016/J.Clinph.2007.02.018  0.644
2007 Vrenken H, Geurts JJ. Gray and normal-appearing white matter in multiple sclerosis: an MRI perspective. Expert Review of Neurotherapeutics. 7: 271-9. PMID 17341175 DOI: 10.1586/14737175.7.3.271  0.364
2007 Bö L, Geurts JJ, van der Valk P, Polman C, Barkhof F. Lack of correlation between cortical demyelination and white matter pathologic changes in multiple sclerosis. Archives of Neurology. 64: 76-80. PMID 17210812 DOI: 10.1001/Archneur.64.1.76  0.684
2006 Vrenken H, Geurts JJ, Knol DL, Polman CH, Castelijns JA, Pouwels PJ, Barkhof F. Normal-appearing white matter changes vary with distance to lesions in multiple sclerosis. Ajnr. American Journal of Neuroradiology. 27: 2005-11. PMID 17032884  0.752
2006 Vrenken H, Geurts JJ, Knol DL, van Dijk LN, Dattola V, Jasperse B, van Schijndel RA, Polman CH, Castelijns JA, Barkhof F, Pouwels PJ. Whole-brain T1 mapping in multiple sclerosis: global changes of normal-appearing gray and white matter. Radiology. 240: 811-20. PMID 16868279 DOI: 10.1148/Radiol.2403050569  0.754
2006 Vrenken H, Pouwels PJ, Geurts JJ, Knol DL, Polman CH, Barkhof F, Castelijns JA. Altered diffusion tensor in multiple sclerosis normal-appearing brain tissue: cortical diffusion changes seem related to clinical deterioration. Journal of Magnetic Resonance Imaging : Jmri. 23: 628-36. PMID 16565955 DOI: 10.1002/Jmri.20564  0.764
2006 Geurts JJ, Reuling IE, Vrenken H, Uitdehaag BM, Polman CH, Castelijns JA, Barkhof F, Pouwels PJ. MR spectroscopic evidence for thalamic and hippocampal, but not cortical, damage in multiple sclerosis. Magnetic Resonance in Medicine : Official Journal of the Society of Magnetic Resonance in Medicine / Society of Magnetic Resonance in Medicine. 55: 478-83. PMID 16463353 DOI: 10.1002/Mrm.20792  0.748
2006 Cover KS, Vrenken H, Geurts JJ, van Oosten BW, Jelles B, Polman CH, Stam CJ, van Dijk BW. Multiple sclerosis patients show a highly significant decrease in alpha band interhemispheric synchronization measured using MEG. Neuroimage. 29: 783-8. PMID 16226894 DOI: 10.1016/J.Neuroimage.2005.08.048  0.536
2005 Vos CM, Geurts JJ, Montagne L, van Haastert ES, Bö L, van der Valk P, Barkhof F, de Vries HE. Blood-brain barrier alterations in both focal and diffuse abnormalities on postmortem MRI in multiple sclerosis. Neurobiology of Disease. 20: 953-60. PMID 16039866 DOI: 10.1016/J.Nbd.2005.06.012  0.596
2005 Geurts JJ, Pouwels PJ, Uitdehaag BM, Polman CH, Barkhof F, Castelijns JA. Intracortical lesions in multiple sclerosis: improved detection with 3D double inversion-recovery MR imaging. Radiology. 236: 254-60. PMID 15987979 DOI: 10.1148/Radiol.2361040450  0.742
2005 Geurts JJ, Bö L, Pouwels PJ, Castelijns JA, Polman CH, Barkhof F. Cortical lesions in multiple sclerosis: combined postmortem MR imaging and histopathology. Ajnr. American Journal of Neuroradiology. 26: 572-7. PMID 15760868  0.743
2005 Geurts JJ, Wolswijk G, Bö L, Redeker S, Ramkema M, Troost D, Aronica E. Expression patterns of Group III metabotropic glutamate receptors mGluR4 and mGluR8 in multiple sclerosis lesions. Journal of Neuroimmunology. 158: 182-90. PMID 15589052 DOI: 10.1016/J.Jneuroim.2004.08.012  0.377
2004 Uitdehaag BM, Geurts JJ, Barkhof F, Polman CH. The utility of MRI in suspected MS: report of the Therapeutics and Technology Assessment Subcommittee. Neurology. 63: 1140; author reply 1. PMID 15452328  0.538
2004 Geurts JJ, Barkhof F, Castelijns JA, Uitdehaag BM, Polman CH, Pouwels PJ. Quantitative 1H-MRS of healthy human cortex, hippocampus, and thalamus: metabolite concentrations, quantification precision, and reproducibility. Journal of Magnetic Resonance Imaging : Jmri. 20: 366-71. PMID 15332241 DOI: 10.1002/Jmri.20138  0.66
2004 Bö L, Geurts JJ, Ravid R, Barkhof F. Magnetic resonance imaging as a tool to examine the neuropathology of multiple sclerosis. Neuropathology and Applied Neurobiology. 30: 106-17. PMID 15043708 DOI: 10.1111/J.1365-2990.2003.00521.X  0.59
2003 Barkhof F, Bruck W, De Groot CJ, Bergers E, Hulshof S, Geurts J, Polman CH, van der Valk P. Remyelinated lesions in multiple sclerosis: magnetic resonance image appearance. Archives of Neurology. 60: 1073-81. PMID 12925362 DOI: 10.1001/Archneur.60.8.1073  0.697
2003 Geurts JJ, Wolswijk G, Bö L, van der Valk P, Polman CH, Troost D, Aronica E. Altered expression patterns of group I and II metabotropic glutamate receptors in multiple sclerosis. Brain : a Journal of Neurology. 126: 1755-66. PMID 12805104 DOI: 10.1093/Brain/Awg179  0.517
Show low-probability matches.